ruthenium has been researched along with sodium (trans-rucl4(dmso)im) in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessio, E; Bergamo, A; Capozzi, I; Cocchietto, M; Mestroni, G; Sava, G | 1 |
| Alessio, E; Capozzi, I; Clerici, K; Gagliardi, G; Mestroni, G; Sava, G | 1 |
| Bergamo, A; Capozzi, I; Clerici, K; Cocchietto, M; Salerno, G; Sava, G | 1 |
3 other study(ies) available for ruthenium and sodium (trans-rucl4(dmso)im)
| Article | Year |
|---|---|
Treatment of residual metastases with Na[trans-RuCl4 (DMSO)lm] and ruthenium uptake by tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm, Residual; Organometallic Compounds; Ruthenium; Survival Analysis | 1996 |
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Female; Flow Cytometry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Ruthenium | 1998 |
Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; Cisplatin; Dimethyl Sulfoxide; DNA, Neoplasm; Doxorubicin; Flow Cytometry; In Vitro Techniques; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred CBA; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured | 1998 |